Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Sep 7.

Published in final edited form as: Chem Soc Rev. 2021 Jul 22;50(17):9794–9816. doi: 10.1039/d1cs00017a

Fig 1. — a Different type of fluorophores discussed in this review. Throughout the manuscript, the fluorophores will be colored green – red as depicted here to highlight their absorption of light. b Parent structures of kinase inhibitors. From here on, modifications made to kinase inhibitor for fluorophore conjugate will be referred as kinase inhibitor analog and shown in magenta. Modifications to the kinase inhibitors will be depicted in blue or purple. c Dasatinib binding to Abl (blue; PBD: 2GQG). d Palbociclib bound to CDK6 (blue; PBD: 5L2T).

Fig 1. — a Different type of fluorophores discussed in this review. Throughout the manuscript, the fluorophores will be colored green – red as depicted here to highlight their absorption of light. b Parent structures of kinase inhibitors. From here on, modifications made to kinase inhibitor for fluorophore conjugate will be referred as kinase inhibitor analog and shown in magenta. Modifications to the kinase inhibitors will be depicted in blue or purple. c Dasatinib binding to Abl (blue; PBD: 2GQG). d Palbociclib bound to CDK6 (blue; PBD: 5L2T).